FOXD1 and lip and oral cavity carcinoma: Lin et al. reported that knockdown of FOXD1 could potentiate radiation effectiveness by down-regulating G3BP2 expression and promoting the activation of TXNIP-related pathways in oral cancer, indicating that targeting FOXD1 might be a good strategy to enhance the radiosensitivity of oral cancer [15].